• Latest Posts

Hemophilia drug from Sanofi and Sobi has license application accepted for priority review by FDA

More News! 22 Nov 2018

First Drug for Rare Inflammation Syndrome Approved by FDA

Swedish Biotech Can Now Fast-Track its Metabolic Disorder Drug

ADVERTISEMENT